Japan's Shionogi Gets Rapid Approval Of Peramivir Flu Drug
This article was originally published in PharmAsia News
Executive SummaryShionogi of Japan received government approval of its Rapiacta (peramivir) intravenous flu drug
You may also be interested in...
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.